Nerve Growth Factor Market: Global Industry Analysis and Forecast (2021-2027)

Nerve Growth Factor Market was valued at US$ 1.0 Bn. in 2021 and the market size is expected to grow at a CAGR of 6.99 % through the forecast period.
Nerve Growth Factor Market Overview:
The nerve growth factor is a neurotrophic growth factor called neutrophin which supports growth and elasticity of neurons of the peripheral and central nervous system. Nerve growth factor (NGF) is a protein responsible for the development and maintenance of sensory and sympathetic neurons, especially the neurons that transmit touch, temperature, and pain sensation.

The nerve growth factor is of several types such as beta-nerve growth factor, gamma- nerve growth factor, alpha- nerve growth factor and others. The nerve growth factor is also associated with type 2 diabetes, obesity, coronary atherosclerosis and other metabolic syndromes.



To Know About The Research Methodology :- Request Free Sample Report

govern the life cycles of neurons, according to new research. NGF regulates the immune system, which is one of its most important tasks. NGF is released in large concentrations by mass cells as a result of this. Axonal growth occurs in neighboring nociceptive neurons as a result of this. As a result, pain perception is heightened in inflamed areas. NGF has been demonstrated to play a role in romantic and love feelings in more recent studies.

The report explores the Nerve Growth Factor Market's segments (Connectivity and Content, and Region). Data has been provided by market participants, and regions (North America, Asia Pacific, Europe, Middle East & Africa, and South America). The MMR market report provides a thorough analysis of the rapid advances that are currently taking place across all industry sectors. Facts and figures, illustrations, and presentations are used to provide key data analysis for the historical period from 2017 to 2021. The report investigates the Nerve Growth Factor Market's drivers, limitations, prospects, and barriers. This MMR report includes investor recommendations based on a thorough examination of the Nerve Growth Factor Market's contemporary competitive scenario.
Nerve Growth Factor Market Dynamics:
A rise in the incidence rate of brain illnesses, as well as an increase in the geriatric population, are driving the nerve growth factor market. Detecting targeted blockages, measuring biological response, and determining genetic predisposition are all expected to benefit from expected technology improvements. The nerve growth factor market is projected to be driven by this. However, a rise in stringent regulatory rules, an increase in overall health-care spending, and expensive clinical trial expenses are expected to constrain the nerve growth factor market in the near future.

Growing cases of Alzheimer’s disease, corneal ulcer, glaucoma, retinitis pigmentosa which causes tissue damage to the immune system drives the nerve growth factor market.

Increased government funding for the innovation of novel treatment and continuous clinical studies using human growth factor for the treatment of various diseases will boost up the global nerve growth factor market.
Nerve Growth Factor Market Segment Analysis:
Based on Type

Nerve growth factor market is segmented on the bases of the type is Beta NGF, Alpha NGF and Gamma NGF.
Beta NGF protein or the Nerve growth factor is mainly involved with the maintenance, growth and proliferation of particular target growth neurons.

Gamma NGF subunit plays an important part in this structure. It cleaves the N-terminal that exists within the beta subunit and operates as a serine protease. As such, it is responsible for activating the protein into the typical NGF complex. Alpha-NGF is an inactive serine proteinase.

Based on indication

Nerve growth factor market is segmented on the bases of the indication is Neurodegenerative disorder, Spinal cord injuries, Eye disorder, Epithelial diseases, Tissue Healing and others.

Neurodegenerative disorders, especially Parkinson and Alzheimer NGF is help to cure from these disease.
When the spinal cord is damaged, the message from the brain cannot get through. The spinal nerves below the level of injury get signals, but they are not able to go up the spinal tracts to the brain. But NGF is promote nerve cell regeneration or improve the function of the nerves that remain after a spinal cord injury.

In eye disorder NGF is used in ocular therapy has been furthest advanced in the treatment of ocular surface disease. NGF is thought to regulate ocular surface homeostasis in multiple ways, including epithelial health, limbal stem cell proliferation, immune modulation, and tear production.

Based on route of administration

Nerve growth factor market is segmented on the bases of the administration Oral, Occular, Parenteral and other.

Oral administration is a route of administration where a substance is taken through the mouth.Ocular administration drugs used to treat eye disorders can be mixed with inactive substances to make a liquid, gel, or ointment so that they can be applied to the eye.

Parenteral route is any route that is not enteral. Parenteral administration can be performed by injection, that is, using a needle and a syringe, or by the insertion of an indwelling catheter.


Nerve Growth Factor Market Regional Insights:
North America and Europe are expected to rule the global nerve growth factor market due to their huge prevalence and incidence of neurodegenerative diseases. Europe is burdened with brain diseases which account for 35% of the total diseases. The growing awareness and escalating research and clinical progress are expected to further push the nerve growth factor market in North America and Europe.

The Asia-Pacific nerve growth factor is expected to grow at a fast pace, driven by the emerging therapies, massive patient base and increasing awareness of brain diseases.
Nerve Growth Factor Market Scope: Inquire before buying



Global Nerve Growth Factor Market


Report Coverage
Details


Base Year:
2021
Forecast Period:
2022-2027


Historical Data:
2017 to 2021
Market Size in 2021:
US $ 1.0 Bn.


Forecast Period 2022 to 2027 CAGR:
6.99%
Market Size in 2027:
US $ 1.5 Bn.


 Segments Covered:
by Type
• Alpha-NGF
• Beta-NGF
• Gamma-NGF
• Others


by Application
• Neurodegenerative Disorders
• Spinal Cord Injuries
• Eye Disorders
• Epithelial Diseases
• Tissue Healing
• Others


by Administration route
• Oral
• Parenteral
• Ocular
• Others


by End-User
• Hospitals
• Specialty Clinics
• Others



Nerve Growth Factor Market by Region
• North America
• Europe
• Asia Pacific
• South America
• Middle East and Africa
Nerve Growth Factor Market Key Players
• Dompe pharmaceutical
• Pfizer Inc.
• Regeneron
• Astellas Pharma Inc.
• Merck KGaA
• Promega Corporation
• Alomone Labs
• Bio-Rad Laboratories, Inc.
• Enzo Life Sciences, Inc.
• Prospec-Tany Technogene Ltd.
• CUSABIO TECHNOLOGY LLC
• Biocare Medical, LLC.
• Eli Lilly & Company
• Teva Pharmaceutical Industries
• Mitsubishi Tanabe Pharma Corporation
• Sanofi

Frequently Asked Questions:

1] What segments are covered in the Global Global Nerve Growth Factor Market report?
Ans. The segments covered in the Global Nerve Growth Factor Market report are based on Type, Indication, Administration of route and End user.

2] Which region is expected to hold the highest share in the Global Global Nerve Growth Factor Market?
Ans. North America region is expected to hold the highest share in the Global Nerve Growth Factor Market.

3] What is the market size of the Global Global Nerve Growth Factor Market by 2027?
Ans. The market size of the Global Nerve Growth Factor Market by 2027 is expected to reach US$ 1.5 Bn.

4] What is the forecast period for the Global Global Nerve Growth Factor Market?
Ans. The forecast period for the Global Nerve Growth Factor Market is 2021-2027.

5] What was the market size of the Global Global Nerve Growth Factor Market in 2021?
Ans. The market size of the Global Nerve Growth Factor Market in 2021 was valued at US$ 1.5 Bn.